Happi-D Capsule SR is a combination medication containing Domperidone 30 mg and Rabeprazole 20 mg, formulated for sustained release to provide effective management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, bloating, and discomfort associated with delayed gastric emptying or gastroparesis. Rabeprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, promoting healing of acid-related mucosal damage and providing symptomatic relief in conditions such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome. The combination of these agents in Happi-D Capsule SR offers a dual mechanism of action, addressing both motility and acid-related components of upper gastrointestinal disorders. This medication is indicated for patients experiencing dyspepsia, reflux esophagitis, and other acid-peptic conditions where delayed gastric emptying is a contributing factor. Administration should be as prescribed by a healthcare professional, with caution advised in patients with known hypersensitivity to either component, significant hepatic impairment, or underlying cardiac conditions. Monitoring for potential side effects such as headache, dry mouth, or gastrointestinal disturbances is recommended during therapy.

Dosage & How to Use